CFO tran­si­tion on the hori­zon at BioN­Tech as Sierk Po­et­ting con­cen­trates on COO du­ties; Centes­sa rides a wave of new ex­ecs af­ter An­toine Yver's ap­point­ment

→ As its Covid-19 vac­cine with Pfiz­er con­tin­ues to in­oc­u­late mil­lions, BioN­Tech is chang­ing CFOs be­gin­ning Ju­ly 1 with Jens Hol­stein step­ping in­to the role pre­vi­ous­ly oc­cu­pied by Sierk Po­et­ting, who will di­rect his full at­ten­tion to his work as COO mov­ing for­ward. Hol­stein was CFO at Mor­phoSys from 2011-20 and held a num­ber of lead­er­ship roles with­in the Fre­se­nius uni­verse be­fore that time.

Po­et­ting has seen BioTech turn in­to a house­hold name since his tenure be­gan in 2014, and he’s been a cru­cial voice on the vac­cine dis­tri­b­u­tion ef­forts, in­di­cat­ing some weeks ago that BioN­Tech has held dis­cus­sions on ramp­ing up ca­pac­i­ty. “There is still room for im­prove­ment. But that will ul­ti­mate­ly al­so de­pend on de­mand,” Po­et­ting told Reuters in late April.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.